artenimol has been researched along with Hypertension, Pulmonary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, H; Cai, L; Fan, S; Huang, X; Li, Y; Wang, L; Yao, Y; Zhao, Z; Zhu, L | 1 |
| Cai, H; Huang, X; Li, Y; Song, L; Wang, L; Wei, J; Xie, M; Yao, Y; Zhang, C; Zhu, L | 1 |
2 other study(ies) available for artenimol and Hypertension, Pulmonary
| Article | Year |
|---|---|
Dihydroartemisinin Attenuates Hypoxia-Induced Pulmonary Hypertension Through the ELAVL2/miR-503/PI3K/AKT Axis.
Topics: Animals; Artemisinins; Cell Proliferation; Cells, Cultured; ELAV-Like Protein 2; Hypertension, Pulmonary; Hypoxia; Mice; MicroRNAs; Myocytes, Smooth Muscle; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pulmonary Artery | 2022 |
Dihydroartemisinin Attenuates Hypoxic Pulmonary Hypertension via the Downregulation of miR-335 Targeting
Topics: Animals; Artemisinins; Cells, Cultured; Down-Regulation; Hypertension, Pulmonary; Hypoxia; Mice; MicroRNAs; Nerve Tissue Proteins; Pulmonary Artery | 2022 |